ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 84 filers reported holding ARGENX SE in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,898,127 | +37.0% | 12,568 | +31.0% | 3.32% | +26.0% |
| Q1 2023 | $3,574,533 | +85.0% | 9,594 | +88.1% | 2.63% | +121.4% |
| Q4 2022 | $1,932,033 | -24.6% | 5,100 | -77.3% | 1.19% | -35.8% |
| Q3 2019 | $2,564,000 | -77.6% | 22,500 | -72.2% | 1.85% | -54.6% |
| Q2 2019 | $11,468,000 | +44.7% | 81,000 | +27.6% | 4.08% | +8.2% |
| Q1 2019 | $7,927,000 | +55.7% | 63,500 | +19.8% | 3.77% | -3.0% |
| Q4 2018 | $5,092,000 | -36.1% | 53,000 | -49.5% | 3.88% | +36.8% |
| Q3 2018 | $7,963,000 | -78.8% | 105,000 | -76.8% | 2.84% | -57.5% |
| Q2 2018 | $37,555,000 | +15.6% | 453,233 | +12.2% | 6.68% | +26.0% |
| Q1 2018 | $32,483,000 | +59.3% | 403,821 | +25.0% | 5.30% | +37.8% |
| Q4 2017 | $20,394,000 | +317.1% | 323,000 | +49.4% | 3.85% | +339.5% |
| Q3 2017 | $4,890,000 | +50.8% | 216,255 | +41.5% | 0.88% | -3.4% |
| Q2 2017 | $3,242,000 | – | 152,837 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |